AIMS/HYPOTHESIS: The mechanisms allowing normalisation of insulin sensitivity and reversal of type 2 diabetes after bilio-pancreatic diversion (BPD) have not been elucidated. We studied whether the expression of genes relevant to mitochondrial biogenesis/function is induced in response to BPD and whether the response differs between morbidly obese patients with normal glucose tolerance (NGT) and patients with type 2 diabetes. METHODS: The effect of stable weight reduction after BPD on metabolic variables and expression of nuclear genes encoding for mitochondrial proteins or regulators of mitochondrial function was investigated in skeletal muscle. Insulin sensitivity was assessed by euglycaemic-hyperinsulinaemic clamp and substrate oxidation by indirect calorimetry. RESULTS: Both NGT and type 2 diabetic patients showed a net improvement of insulin sensitivity, with the latter also showing blood glucose normalisation. NGT patients had a large increase in glucose oxidation and substantial reduction in lipid oxidation. In contrast, type 2 diabetic patients had a blunted response to BPD in terms of glucose oxidation. NGT patients showed increased expression of genes encoding mitofusin 2, porin or citrate synthase; no significant changes were detected in diabetic patients. The expression of genes regulating mitochondrial activity (PGC-1beta [also known as PPARGC1B], PGC-1alpha [also known as PPARGC1A], PPARdelta [also known as PPARD], SIRT1) was induced only in NGT patients. CONCLUSIONS/ INTERPRETATION: These findings indicate that weight loss after BPD exerts a beneficial effect on insulin sensitivity via mechanisms that are independent of the expression of genes involved in mitochondrial biogenesis/activity. Furthermore, the observation that gene expression is not altered with weight loss in type 2 diabetic patients while it is induced in NGT patients suggests a heritable component.
AIMS/HYPOTHESIS: The mechanisms allowing normalisation of insulin sensitivity and reversal of type 2 diabetes after bilio-pancreatic diversion (BPD) have not been elucidated. We studied whether the expression of genes relevant to mitochondrial biogenesis/function is induced in response to BPD and whether the response differs between morbidly obesepatients with normal glucose tolerance (NGT) and patients with type 2 diabetes. METHODS: The effect of stable weight reduction after BPD on metabolic variables and expression of nuclear genes encoding for mitochondrial proteins or regulators of mitochondrial function was investigated in skeletal muscle. Insulin sensitivity was assessed by euglycaemic-hyperinsulinaemic clamp and substrate oxidation by indirect calorimetry. RESULTS: Both NGT and type 2 diabeticpatients showed a net improvement of insulin sensitivity, with the latter also showing blood glucose normalisation. NGT patients had a large increase in glucose oxidation and substantial reduction in lipid oxidation. In contrast, type 2 diabeticpatients had a blunted response to BPD in terms of glucose oxidation. NGT patients showed increased expression of genes encoding mitofusin 2, porin or citrate synthase; no significant changes were detected in diabeticpatients. The expression of genes regulating mitochondrial activity (PGC-1beta [also known as PPARGC1B], PGC-1alpha [also known as PPARGC1A], PPARdelta [also known as PPARD], SIRT1) was induced only in NGT patients. CONCLUSIONS/ INTERPRETATION: These findings indicate that weight loss after BPD exerts a beneficial effect on insulin sensitivity via mechanisms that are independent of the expression of genes involved in mitochondrial biogenesis/activity. Furthermore, the observation that gene expression is not altered with weight loss in type 2 diabeticpatients while it is induced in NGT patients suggests a heritable component.
Authors: Francesc X Soriano; Marc Liesa; Daniel Bach; David C Chan; Manuel Palacín; Antonio Zorzano Journal: Diabetes Date: 2006-06 Impact factor: 9.461
Authors: Joseph T Rodgers; Carlos Lerin; Wilhelm Haas; Steven P Gygi; Bruce M Spiegelman; Pere Puigserver Journal: Nature Date: 2005-03-03 Impact factor: 49.962
Authors: Steven C Hunt; Sandra J Hasstedt; Yuanpei Xin; Brian K Dalley; Brett A Milash; Emanuel Yakobson; Richard E Gress; Lance E Davidson; Ted D Adams Journal: Obesity (Silver Spring) Date: 2011-08-04 Impact factor: 5.002
Authors: Cyrus Jahansouz; Federico J Serrot; Brigitte I Frohnert; Rocio E Foncea; Robert B Dorman; Bridget Slusarek; Daniel B Leslie; David A Bernlohr; Sayeed Ikramuddin Journal: Obes Surg Date: 2015-12 Impact factor: 4.129
Authors: L E Wright; A E Brandon; A J Hoy; G-B Forsberg; C J Lelliott; J Reznick; L Löfgren; J Oscarsson; M Strömstedt; G J Cooney; N Turner Journal: Diabetologia Date: 2011-02-18 Impact factor: 10.122
Authors: Marc Schneeberger; Marcelo O Dietrich; David Sebastián; Mónica Imbernón; Carlos Castaño; Ainhoa Garcia; Yaiza Esteban; Alba Gonzalez-Franquesa; Ignacio Castrillón Rodríguez; Analía Bortolozzi; Pablo M Garcia-Roves; Ramon Gomis; Ruben Nogueiras; Tamas L Horvath; Antonio Zorzano; Marc Claret Journal: Cell Date: 2013-09-26 Impact factor: 41.582
Authors: Dong-Ho Han; Chad R Hancock; Su Ryun Jung; Kazuhiko Higashida; Sang Hyun Kim; John O Holloszy Journal: PLoS One Date: 2011-05-12 Impact factor: 3.240